Artiva Biotherapeutics (ARTV) Amortizatization of Intangibles (2023 - 2026)

Artiva Biotherapeutics (ARTV) has reported Amortizatization of Intangibles for 4 consecutive years, with $199000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 72.48% year-over-year to $199000.0; the TTM figure through Mar 2026 stood at $1.4 million (down 49.72% YoY), while the FY2025 annual figure was $1.9 million, down 19.73% from the prior year.
• Amortizatization of Intangibles declined to $199000.0 in Q1 2026 per ARTV's latest filing, from $291000.0 in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $1.0 million in Q4 2024 and bottomed at $199000.0 in Q1 2026.
• Historically, Amortizatization of Intangibles has averaged $470400.0 across 4 years, with a median of $362500.0 in 2024.
• Annual changes were most pronounced in 2024 — Amortizatization of Intangibles surged 268.2% — and 2026, when it tumbled 72.48%.
• Artiva Biotherapeutics' Amortizatization of Intangibles stood at $283000.0 in 2023, then soared by 268.2% to $1.0 million in 2024, then slumped by 72.07% to $291000.0 in 2025, then tumbled by 31.62% to $199000.0 in 2026.
• Business Quant data shows ARTV's Amortizatization of Intangibles at $199000.0 in Q1 2026, $291000.0 in Q4 2025, and $357000.0 in Q3 2025.